Category: Finance
Confessions of a Day Trader: Miners in front, banks bringing up the rear. What are the odds?
Each week, Stockhead’s resident day trader gives us a peek at the highs and lows of his trading diary and hints at what might be [more…]
Got copper? Here are the stocks looking to make a dent in the supply deficit
Experts agree, we need a lot more copper to reach net zero but with supply from large orebodies declining, little discoveries are not going to [more…]
Traders’ Diary: What will happen now that The Fed’s rate cycle has hit terminal velocity?
THE WEEK THAT WAS Australian equity markets ended last week on another unfamiliar high note, the ASX200 closing up +3.4% from Monday’s intra-day low. In [more…]
Hot Money Monday: Trend is your friend as these ASX small caps ride high on momentum
We’ve all heard that “trend is your friend.” And who doesn’t like riding a trend? Trend or momentum trading involves buying a stock that has [more…]
Rise and Shine: Everything you need to know before the ASX opens
Good morning everyone, and welcome to Monday, 6 November. On Stockhead today… Experts agree, we need a lot more copper to reach net zero but [more…]
Pure Hydrogen powers ahead on road to net zero
Pure Hydrogen rounds out September quarter with marquee board appointment Agreement executed for third hydrogen fuel cell electric truck trial Investee company H2X Global advances [more…]
SUNDAY ROAST: The stocks that lit a fire under our experts this week
Guy le Page Guy le Page has gone all nerd rock on us this week with a nearology play piggybacking $526m moonshot WA1 Resources, and [more…]
CRITERION: Paradigm’s set for a proper knees-up if its arthritis fighter is the real deal
Despite improving sentiment in the life sciences sector, investors are savagely discounting pre-clinical drug developers with a long path to approval. That’s fair enough – [more…]
Barry FitzGerald: Comp this – a $160m gold producer that’s not unlike a recent $1.75bn acquisition
One of the biggest mine deals of the year has been concluded without much fanfare. Garimpeiro is talking about the $US950-$US1.1 billion acquisition from Glencore [more…]
ScoPo’s Powerplays: Who fancies 22 minutes of exercise? And ASX health stocks are up (finally)
ASX health stocks rise in past five days in line with broader markets Mach7 Technologies reports record quarterly sales orders for Q1 FY24 Aroa maintains [more…]
